99% Savings - Buy Just @1 Rs X
Xtroz 1 gm Injection is a prescription medicine that is available as a Injection. It is typically used for the treatment of Pancreatic Cancer, Non-Small Cell Lung Cancer. Xtroz 1 gm Injection also has some secondary and off-label uses. These are listed below.
The right dosage of Xtroz 1 gm Injection depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Xtroz 1 gm Injection have been listed ahead. Normally, these side effects of Xtroz 1 gm Injection are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Xtroz 1 gm Injection's effect is Unknown during pregnancy and Severe for lactating mothers. In addition, Xtroz 1 gm Injection's effects on the liver, heart and kidney are discussed below in the Xtroz 1 gm Injection related warnings section.
Xtroz 1 gm Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Xtroz 1 gm Injection in conditions like Heart Disease, Infections. The section on Xtroz 1 gm Injection contraindications lists all such conditions.
Drug reaction of Xtroz 1 gm Injection with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Xtroz 1 gm Injection is safe while driving, and is is addictive in nature.
Xtroz 1 gm Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Adult |
|
Geriatric |
|
Is the use of Xtroz 1 gm Injection safe for pregnant women?
The effects of Xtroz on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Xtroz 1 gm Injection safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Xtroz. It should only be taken after medical advice.
What is the effect of Xtroz 1 gm Injection on the Kidneys?
Xtroz rarely harms the kidneys.
What is the effect of Xtroz 1 gm Injection on the Liver?
Xtroz can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Xtroz 1 gm Injection on the Heart?
Xtroz has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Xtroz 1 gm Injection unless your doctor advises you to do so -
Is this Xtroz 1 gm Injection habit forming or addictive?
No, you will not get addicted to Xtroz 1 gm Injection.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Xtroz 1 gm Injection as it does not make you drowsy.
Is it safe?
Xtroz 1 gm Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Xtroz 1 gm Injection in mental disorders is not effective.
Interaction between Food and Xtroz 1 gm Injection
There isn't any research available on the side effects of taking Xtroz 1 gm Injection with food.
Interaction between Alcohol and Xtroz 1 gm Injection
Due to lack of research, there is no information about the side effects of taking Xtroz 1 gm Injection with alcohol.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gemzar® (Gemcitabine HCl)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 612-614